Kim; Kwangmeyung

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kim; Kwangmeyung.The latest application filed is for "pharmaceutical composition for combination therapy for preventing or treating cancer containing tumor-specific drug conjugate and anti-pd-l1 antibody as active ingredients".

Company Profile

8.12.11

Kim; Kwangmeyung - Seoul KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Immunoregulatory protein-siRNA complex having anticancer activity Grant 11,246,939 - Kim , et al. February 15, 2	2022-02-15
Pharmaceutical Composition For Combination Therapy For Preventing Or Treating Cancer Containing Tumor-specific Drug Conjugate And Anti-pd-l1 Antibody As Active Ingredients App 20210179681 - KIM; Kwangmeyung ; et al.	2021-06-17
Therapeutic agent for treating cancer comprising anti-miRNA-albumin composite Grant 11,015,197 - Kim , et al. May 25, 2	2021-05-25
Nanocage and use thereof Grant 10,905,774 - Nam , et al. February 2, 2	2021-02-02
IMMUNOREGULATORY PROTEIN-siRNA COMPLEX HAVING ANTICANCER ACTIVITY App 20210015931 - KIM; Sun Hwa ; et al.	2021-01-21
Tumor cell-specific responsive self-assembling drug nanoconjugate Grant 10,610,602 - Kim , et al.	2020-04-07
Therapeutic Agent For Treating Cancer Comprising Anti-mirna-albumin Composite App 20200071698 - KIM; Sun Hwa ; et al.	2020-03-05
Novel Nanocage And Use Thereof App 20190216947 - NAM; Gi Hoon ; et al.	2019-07-18
Tumor-targeting Photosensitizer-drug Conjugate, Method For Preparing Same And Pharmaceutical Composition For Preventing Or Treat App 20190201538 - KIM; Kwangmeyung ; et al.	2019-07-04
Tumor Cell-specific Responsive Self-assembling Drug Nanoconjugate App 20190083637 - KIM; Kwangmeyung ; et al.	2019-03-21
Glycopeptide for contrast agent targeting cancer cells and contrast agent kit containing the same Grant 10,213,515 - Kim , et al. Feb	2019-02-26
Protein nanoparticle linked with cancer specific epitope and composition for cancer immunotherapy comprising the same Grant 10,206,987 - Lee , et al. Feb	2019-02-19
Glycopeptide For Contrast Agent Targeting Cancer Cells And Contrast Agent Kit Containing The Same App 20170216460 - KIM; Kwangmeyung ; et al.	2017-08-03
Protein Nanoparticle Linked With Cancer Specific Epitope And Composition For Cancer Immunotherapy Comprising The Same App 20170112910 - Lee; Jeewon ; et al.	2017-04-27
Method for polymerizing a small oligonucleotide, and use of a high-molecular oligonucleotide prepared by the polymerization method Grant 8,530,047 - Kim , et al. September 10, 2	2013-09-10
Human serum albumin-siRNA nano-sized carrier system Grant 8,513,402 - Kim , et al. August 20, 2	2013-08-20
Nanoparticles of light emissive polymers and preparation method thereof Grant 8,367,042 - Kim , et al. February 5, 2	2013-02-05
HYMAN SERUM ALBUMIN-siRNA NANO-SIZED CARRIER SYSTEM App 20120083455 - KIM; Kwangmeyung ; et al.	2012-04-05
Method For Polymerizing A Small Oligonucleotide, And Use Of A High-molecular Oligonucleotide Prepared By The Polymerization Method App 20110274930 - Kim; KwangMeyung ; et al.	2011-11-10
Nanoparticles Of Light Emissive Polymers And Preparation Method Thereof App 20100290999 - KIM; Sehoon ; et al.	2010-11-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.